IRON-ABSORPTION IN NON-TRANSFUSED IRON LOADING ANEMIAS - PREDICTION OF RISK FOR IRON LOADING, AND RESPONSE TO IRON CHELATION TREATMENT, IN BETA-THALASSEMIA INTERMEDIA AND CONGENITAL SIDEROBLASTIC ANEMIAS

被引：0
|
作者：
PIPPARD, MJ
WEATHERALL, DJ
机构：
来源：
HAEMATOLOGIA | 1984年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：407 / 414
页数：8
相关论文
共 36 条
  • [31] The effect of combined chelation therapy in the treatment of severe myocardial iron loading in beta Thalassaemia major.
    Tanner, MA
    Galanello, R
    Dessi, C
    Westwood, MA
    Pennell, DJ
    BLOOD, 2005, 106 (11) : 39B - 39B
  • [32] A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis
    Cazzola, M
    BorgnaPignatti, C
    Locatelli, F
    Ponchio, L
    Beguin, Y
    DeStefano, P
    TRANSFUSION, 1997, 37 (02) : 135 - 140
  • [33] Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia (vol 83, pg 238, 2014)
    El Sayed, Salah Mohamed
    Abou-Taleb, Ashraf
    Mahmoud, Hany Salah
    Baghdadi, Hussam
    Maria, Reham A.
    Ahmed, Nagwa Sayed
    Nabo, Manal Mohamed Helmy
    MEDICAL HYPOTHESES, 2015, 85 (02) : 239 - 239
  • [34] Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of beta-thalassemia and sickle cell syndromes Italian patients
    Renda, Maria Concetta
    Renda, Disma
    Piazza, Angela
    Calvaruso, Giuseppina
    Fecarotta, Emanuela
    Giangreco, Antonino
    Maggio, Aurelio
    THALASSEMIA REPORTS, 2014, 4 (02) : 28 - 31
  • [35] IRON CHELATION THERAPY IN HEREDITARY HEMOCHROMATOSIS AND THALASSEMIA INTERMEDIA: REGULATORY AND NON REGULATORY MECHANISMS OF INCREASED IRON ABSORPTION [Kontoghiorghes GJ, Spyrou A, Kolganou A. Hemoglobin. 2010;34(3);251-264]
    Nick, H. P.
    HEMOGLOBIN, 2011, 35 (02) : 175 - 179
  • [36] MRI T2☆ DEMONSTRATES REDUCED CARDIAC IRON BURDEN FOLLOWING MODERATE- TO HIGH-DOSE DEFERASIROX TREATMENT IN CHRONICALLY TRANSFUSED BETA-THALASSEMIA PATIENTS
    Wood, J.
    Thompson, A. A.
    Paley, C.
    Kang, B.
    Giardina, P.
    Harmatz, P.
    Virkus, J.
    Coates, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 335 - 336
1234